FURTHER EVIDENCE IN SUPPORT OF BENEFICIAL EFFECTS OF FXR AGONISTS IN BILE ACID DIARRHOEA

被引：0
|
作者：
Walters, Julian [1 ,2 ]
机构：
[1] Imperial Coll Healthcare NHS Trust, London, England
[2] Imperial Coll London, London, England
来源：
GUT | 2021年 / 70卷
关键词：
D O I：
10.1136/gutjnl-2020-bsgcampus.422
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P348
引用
收藏
页码：A221 / A221
页数：1
相关论文
共 50 条
  • [1] Beneficial effects of bile acid receptor agonists in pulmonary disease models
    Comeglio, Paolo
    Morelli, Annamaria
    Adorini, Luciano
    Maggi, Mario
    Vignozzi, Linda
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (11) : 1215 - 1228
  • [2] FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption
    Jung, Diana
    Inagaki, Takeshi
    Gerard, Robert D.
    Dawson, Paul A.
    Kliewer, Steven A.
    Mangelsdorf, David J.
    Moschetta, Antonio
    JOURNAL OF LIPID RESEARCH, 2007, 48 (12) : 2693 - 2700
  • [3] Synthesis and Biological Evaluation of a Series of Bile Acid Derivatives as FXR Agonists for Treatment of NASH
    Xiao, Hualing
    Li, Peng
    Li, Xiaolin
    He, Haiying
    Wang, Jianhua
    Guo, Fengxun
    Zhang, Jiliang
    Wei, Luxia
    Zhang, Hongmei
    Shi, Yueyuan
    Hou, Lijuan
    Shen, Liang
    Chen, Zhengxia
    Du, Chunyan
    Fu, Shouliang
    Zhang, Pengtao
    Hao, Fei
    Wang, Ping
    Xu, Deming
    Liang, Wei
    Tian, Xin
    Zhang, Aiming
    Cheng, Xingdong
    Yang, Ling
    Wang, Xiangjian
    Zhang, Xiquan
    Li, Jian
    Chen, Shuhui
    ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (12): : 1246 - 1251
  • [4] A NOVEL, RATIONAL APPROACH TO TREATING PRIMARY BILE ACID DIARRHOEA: A PROOF OF CONCEPT STUDY OF THE FXR AGONIST OBETICHOLIC ACID
    Johnston, I.
    Nolan, J. D.
    Dew, T.
    Shapiro, D.
    Walters, J. R.
    GUT, 2013, 62 : A127 - A128
  • [5] Mechanistic Pharmacokinetic Modeling Revealed Functional Increase in Bile Acid Efflux by the FXR Agonists Obeticholic Acid and Chenodeoxycholic Acid
    Guo, Cen
    Edwards, Jeffrey
    LaCerte, Carl
    Freeman, Kimberly M.
    Brouwer, Kenneth R.
    Brouwer, Kim L. R.
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2017, 44 : S90 - S90
  • [6] ROLE OF FXR CONTROLLED Chop IN MEDIATING BILE ACID EFFECTS IN NAFLD
    Fuchs, C. D.
    Claudel, T.
    Halilbasic, E.
    Jha, P.
    Spindelboeck, W.
    Stojakovic, T.
    Trauner, M.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S689 - S689
  • [7] Discovery, optimization, and evaluation of non-bile acid FXR/TGR5 dual agonists
    Miyata, Sachiho
    Kawashima, Yuji
    Sakai, Miku
    Matsubayashi, Masaya
    Motoki, Keisuke
    Miyajima, Yui
    Watanabe, Yousuke
    Chikamatsu, Noriko
    Taniguchi, Tetsuya
    Tokuyama, Ryukou
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [8] Semisynthetic Bile Acid FXR and TGR5 Agonists: Physicochemical Properties, Pharmacokinetics, and Metabolism in the Rat
    Roda, Aldo
    Pellicciari, Roberto
    Gioiello, Antimo
    Neri, Flavia
    Camborata, Cecilia
    Passeri, Daniela
    De Franco, Francesca
    Spinozzi, Silvia
    Colliva, Carolina
    Adorini, Luciano
    Montagnani, Marco
    Aldini, Rita
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2014, 350 (01): : 56 - 68
  • [9] Discovery and Optimization of Non-bile Acid FXR Agonists as Preclinical Candidates for the Treatment of Nonalcoholic Steatohepatitis
    Li, Junyou
    Liu, Mengqi
    Li, Yazhou
    Sun, Dan-dan
    Shu, Zhihao
    Tan, Qian
    Guo, Shimeng
    Xie, Rongrong
    Gao, Lixin
    Ru, Hongbo
    Zang, Yi
    Liu, Hong
    Li, Jia
    Zhou, Yu
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (21) : 12748 - 12772
  • [10] Discovery, optimization, and evaluation of non-bile acid FXR/TGR5 dual agonists
    Sachiho Miyata
    Yuji Kawashima
    Miku Sakai
    Masaya Matsubayashi
    Keisuke Motoki
    Yui Miyajima
    Yousuke Watanabe
    Noriko Chikamatsu
    Tetsuya Taniguchi
    Ryukou Tokuyama
    Scientific Reports, 11
12345